AstraZeneca pulls its COVID vaccine from European market

  • 📰 timescolonist
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 75%

France Nouvelles Nouvelles

France Dernières Nouvelles,France Actualités

LONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator.

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator.

AstraZeneca's COVID-19 vaccine was first given the nod by the EMA in January 2021. Within weeks, however, concerns grew about the vaccine's safety, when dozens of countries suspended the vaccine's use after unusual but rare blood clots were detected in a small number of immunized people. The EU regulator concluded AstraZeneca's shot didn't raise the overall risk of clots, but doubts remained.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 15. in FR
 

Merci pour votre commentaire. Votre commentaire sera publié après examen.

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

European Medicines Agency pulls authorization for AstraZeneca’s COVID-19 shot, at company’s requestAstraZeneca’s COVID-19 vaccine was first given the nod by the EMA in January 2021. Within weeks, however, concerns grew about the vaccine’s safety
La source: globeandmail - 🏆 5. / 92 Lire la suite »

European Medicines Agency pulls authorization for AstraZeneca's COVID shot, at company's requestLONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator.
La source: timescolonist - 🏆 15. / 75 Lire la suite »